secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2024-01-10T23:59:59+00:00
Accession:  0001493152-24-001892
Event type: regulatory
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics regains Nasdaq minimum bid price compliance; stock continues listing
--------------------------------------------------------------------------------

- Received Nasdaq notice confirming compliance with minimum bid price rule (Rule 5550(a)(2)).
- Compliance met on Jan 4, 2024 after 10 consecutive trading days with closing bid price over $1.00.
- Stock will continue on Nasdaq Capital Market under discretionary panel monitor until June 28, 2024.
- Previously notified of deficiency on Sep 27, 2023 for failing to maintain $1.00 closing bid for 30 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224001892/0001493152-24-001892-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315224001892/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-001892

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer